Global

Jul 09, 2018
Raman Sehgal talks to three industry leaders for their insights on the challenges faced across the life science sector and how the EMA needs to respond.
Jul 09, 2018
Global pharma companies and Japan can create a win-win situation through a new pricing mechanism, writes Nobuko Kobayashi.
Jul 07, 2018
Pharmaceutical Executive
Peter Young explores the prospects—and related challenges—for Chinese life science as it aggressively pursues new growth areas.
Jul 07, 2018
Filip Conic outlines the market-access approaches and commercial strategies to unlock the growth potential in the Southeastern and Eastern European region.
Jun 21, 2018
China's nurse educator program aims to improve quality of care and make life simpler for physicians handling high patient load. Sebastian Bather reports.
Jun 19, 2018
On May 1, China eliminated the tariff on 28 categories of imported drugs. Jin Zhang looks at the implications for foreign and domestic pharma companies.
Jun 19, 2018
Figuring out the workings of the EU in topics related to health can be akin to deciphering Egyptian hieroglyphs, making it challenging for companies to plan ahead, writes Reflector.
Jun 18, 2018
Pharmaceutical Executive
Weighing the crossover effect of US’s new pricing blueprint. 
Jun 01, 2018
The PD-1/PD-L1 market in China is heating up and companies there have made a series of advances, writes Jin Zhang.
May 16, 2018
Pharmaceutical Executive
Pair of EU meetings, while well-meant, offered little action and beg the question—what’s the true merit in working together?
native1_300x100
lorem ipsum